BriaCell gets court approval for spin-out of BriaPro Therapeutics, effective Aug 31, 2023

BriaCell Therapeutics Corp.

Court approved spin-out of BriaPro Therapeutics with pipeline assets including Bria-TILsRx and PKCδ inhibitors.
Effective date expected August 31, 2023; SpinCo to be ~2/3 owned by BriaCell and ~1/3 by BriaCell shareholders.
Shareholders receive one SpinCo share and one new BriaCell share for each old share held.
BriaCell remains listed on Nasdaq and TSX; SpinCo to be unlisted reporting issuer in Canada.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.